Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Breakdown of Sanofi-Genzyme Deal

October 5, 2010 7:01 am | News | Comments

Here's how French pharmaceutical giant Sanofi-Aventis SA, which has initiated a hostile takeover attempt for Genzyme Corp. of Cambridge, Mass., describes how the proposed $18.5 billion deal would benefit the two companies and their shareholders.

TOPICS:

Merck Wants Fosamax Verdict Overturned

October 5, 2010 6:56 am | News | Comments

Merck & Co. says it will seek a new trial or even a ruling in its favor after a federal judge slashed the jury verdict against the drugmaker in the case of a woman alleging Merck's osteoporosis drug severely damaged her jaw.

TOPICS:

Gamma Radio HPLC Detector

October 4, 2010 8:24 am | Product Releases | Comments

LabLogic’s innovative Flow-RAM is a gamma radio HPLC detector specifically developed for PET and SPECT applications – the company’s response to five years’ feedback from customers in PET centres and nuclear medicine departments.

TOPICS:
Advertisement

Reference Dye

October 4, 2010 8:12 am | Product Releases | Comments

SsoFast EvaGreen Supermix with low ROX, now available from Bio-Rad Laboratories, Inc., enhances the speed, reliability, and sensitivity of qPCR experiments performed on instruments requiring ROX reference dye.

TOPICS:

Pharmatek Expands Manufacturing Capabilities

October 4, 2010 7:59 am | News | Comments

Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has added roller compaction to its solid oral dosage form manufacturing capabilities.

TOPICS:

Mallinckrodt Has Become Avantor

October 4, 2010 7:54 am | News | Comments

Mallinckrodt Baker will now be known as Avantor Performance Materials, company officials announced as they unveiled a new name and identity following the recent acquisition by an affiliate of New Mountain Capital.

TOPICS:

Immune Boost May Protect Newborns from AIDS

October 4, 2010 7:46 am | News | Comments

Researchers at Oregon Health & Science University may have uncovered a new weapon for combating HIV as it is passed from mother to newborn child.

TOPICS:

Heart-Lung Machine to Advance Safety Testing

October 4, 2010 7:42 am | News | Comments

Harvard bioengineers have been awarded more than $3 million in funding from the National Institutes of Health and the U.S. Food and Drug Administration to develop a "Heart-Lung Micromachine" that will accelerate drug safety and efficacy testing.

TOPICS:
Advertisement

CureVac Announces Data from Cancer Vaccine Trial

October 4, 2010 7:27 am | News | Comments

CureVac GmbH announced first data from an open-label phase 1/2a clinical trial of its mRNA vaccine CV9103 in patients with hormone-refractory prostate cancer with rising PSA and existing metastasis in the vast majority of patients.

TOPICS:

South Africa to Market Mood-Elevating Plant

October 4, 2010 7:20 am | by Jenny Gross | News | Comments

For hundreds of years, indigenous South Africans have chewed a plant they say reduces stress, relieves hunger, sedates and elevates moods. Now they have a license to study and market it, and plan to sell it over-the-counter worldwide.

TOPICS:

Pre-Existing Condition Insurance Plan Off to Rocky Start

October 4, 2010 7:03 am | by Ricardo Alonzo-Zaldivar | News | Comments

It's a centerpiece of President Barack Obama's health care remake, a lifeline available right now to vulnerable people whose medical problems have made them uninsurable.

TOPICS:

Sanofi Launches Hostile Takeover of Genzyme

October 4, 2010 7:01 am | by Greg Keller | News | Comments

France's Sanofi-Aventis launched an $18.5 billion hostile takeover offer for Genzyme Corp., stepping up its effort to capture the U.S. biotech company's promising drugs for high cholesterol and lucrative treatments for rare genetic disorders.

TOPICS:

Site-specific, Sustained-release Nimodipine to Prevent Vasospasm

October 4, 2010 6:35 am | by R. Loch Macdonald, MD, PhD, Chief Scientific Officer Edge Therapeutics, Inc., Som-Ming Leung, PhD, Associate Director of Corporate Operations Edge Therapeutics, Inc. | Articles | Comments

Cerebral vasospasm is a common and potentially catastrophic delayed complication of subarachnoid hemorrhage (SAH). Subarachnoid hemorrhage is bleeding into the cerebral spinal fluid and usually is due to rupture of a brain aneurysm or to head trauma.

TOPICS:

Disease-modifying Therapies for Parkinson’s and Alzhiemer’s

October 4, 2010 6:08 am | by Roche, Basel, Switzerland | Articles | Comments

According to the latest statistics from the WHO, there are currently around 35 million people diagnosed with Alzheimer’s disease. Additionally, Parkinson’s disease, the most common motor disorder, affects about 0.1% to 0.2% of the western population.

TOPICS:

Chemotaxis Assay Plate

October 1, 2010 8:15 am | Product Releases | Comments

TTP LabTech has announced a high throughput solution for chemotaxis research using the Acumen eX3 microplate cytometer and the iuvo Chemotaxis Assay Plate from BellBrook Labs.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading